Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
allium cepa extract
- Development stage
- Phase 3
- Administration
- Topical, Oral
01
Overview
Allium cepa extract is derived from the common onion (Allium cepa L.) and contains bioactive compounds including flavonoids (particularly quercetin), sulfur compounds, and other phytochemicals. It possesses anti-inflammatory, antioxidant, antimicrobial, and wound-healing properties. The extract is used in both traditional medicine and modern formulations for various conditions including respiratory disorders, scar management, and allergic conditions.
- Brand names
- ContractubexMederma
- Other names
- onion extractbulbus allii cepae
02
Targets
MMP9 (Matrix metalloproteinase-9)MMP2 (Matrix metalloproteinase-2)COX15-LOX (Lysyl Oxidase)ADORA2A (Adenosine A₂A Receptor)NF-κB
Beyond the preview
Go deeper on allium cepa extract.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on allium cepa extract.